Specific Use-result Surveillance of Spiriva Respimat in asthmatics (patients with mild to moderate persistent asthma) (Specific Use-result Surveillance in asthmatics)First published 22/06/2017 Last updated 01/04/2024 EU PAS number: EUPAS19173StudyFinalised
Yukako Ogi zzCDMJP_PV_PMS@boehringer-ingelheim.comStudy contactzzCDMJP_PV_PMS@boehringer-ingelheim.com